Pharmaceutical management of patients with an enterostomy device – Prospective study to optimize medication and avoid drug-related problems in patients with an artificial bowel outlet

Pharmaceutical management of patients with an enterostomy device – Prospective study to optimize medication and avoid drug-related problems in patients with an artificial bowel outlet - PharMEnt

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00027291

Enrollment

Registered

2021-12-01

Start date

2022-02-14

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with enterostomy (new or existing) Z93.2 Z93.3

Interventions

Group 1: Patients admitted to the UKE with an enterostomy (new or existing stoma) will undergo an intensified pharmaceutical management as part of the intervention study. For this purpose, the medicat

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Patients with enterostoma (new or existing enterostoma) - Able to communicate in German - Written informed consent to participate in the study

Exclusion criteria

Exclusion criteria: non-applicable inclusion criteria

Design outcomes

Primary

Measure	Time frame
1) Relevance of pharmaceutical interventions for solving drug-related problems in patients with enterostoma	—

Secondary

Measure	Time frame
1) Classification of drug-related problems and resulting pharmaceutical interventions in patients with enterostoma 2) Evaluation of pharmaceutical care by patients with enterostoma 3) Evaluation of continuous pharmaceutical care at the interface between inpatient and outpatient settings	—

Countries

Germany

Contacts

Public ContactVivien Berger

Klinikapotheke

v.berger@uke.de040/741058517

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026